ARTICLE | Finance
Fruitful partnerships
VelosBio marks the first start-up to emerge from Arix’s partnerships
October 5, 2018 11:20 PM UTC
Arix Bioscience plc (LSE:ARIX) leveraged its partnership with Takeda Ventures to co-lead a $58 million series A round for antibody-drug company VelosBio Inc., a sign that the VC’s strategic partnerships are finally bearing fruit.
Also participating in the round, which closed Oct. 1., were co-lead investor Sofinnova Ventures, new investors Pappas Ventures and Chiesi Ventures and fellow existing investor Decheng Capital...